Literature DB >> 26131131

Association between aldosterone synthase (CYP11B2) -344C/T polymorphism and atrial fibrillation among Han and Kazak residents of the Xinjiang region.

Wu-Hong Lu1, Maerjiaen Bayike2, Ji-Wen Liu3, Shanshan Wang4, Xiang Xie5, Yu-Chun Yang4, Fen Liu6, Na Li4, Zhi-Qiang Liu4, Peng-Yi He4.   

Abstract

OBJECTIVES: Atrial fibrillation (AF) is one the most common and complex types of clinical arrhythmia syndromes. In recent years, an association between CYP11B2 gene polymorphisms and atrial myocardial fibrosis has received a significant amount of attention. This study explores the relationship between CYP11B2 gene-344C/T polymorphism and AF among Kazak and Han residents in the Xinjiang region and further clarifies the molecular mechanisms of atrial fibrillation.
METHODS: The study is a case-control study using traditional methods. We selected 156 Kazak and 203 Han patient cases in the Xinjiang region who had non-valvular atrial fibrillation as well as 307 Kazak and 418 Han cases of non-AF patients as a control group. Blood samples were collected, and DNA was extracted from the peripheral blood samples. The presence of the CYP11B2 gene-344C/T polymorphism was determined using polymerase chain reaction-restriction enzyme fragment length polymorphism (PCR-RFLP). Differences in the genotypes and allele distributions among the 2 groups were compared using Statistical Package for Social Science (SPSS) 17.0 statistical software. Student's t test, the chi-squared test and logistic regression methods were used for the data analysis.
RESULTS: The genotypes of both ethnic groups followed a Hardy-Weinberg genetic equilibrium distribution. The 2 patient groups, compared with their respective control groups, showed significant dominant models in CYP11B2 gene-344C/T polymorphism genotype frequency and B1 allele frequency (P<0.05). The frequencies of the CYP11B2 gene-344C/T polymorphism in the Kazak patient group were higher compared with the control groups (P<0.05). The frequencies of the CYP11B2 gene-344C/T polymorphisms in the Han patient group was also higher compared with the control group (P<0.05). Logistic regression analysis showed that the frequencies of the CYP11B2 gene-344C/T genotypes were significantly different between the Kazak and Han patient groups and the control groups.
CONCLUSION: CYP11B2 gene -344C/T polymorphism is associated with AF.

Entities:  

Keywords:  Atrial fibrillation; CYP11B2 gene polymorphism; aldosterone

Year:  2015        PMID: 26131131      PMCID: PMC4484025     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  20 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

2.  Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials.

Authors:  Franz H Messerli; Harikrishna Makani; Alexandre Benjo; Jorge Romero; Carlos Alviar; Sripal Bangalore
Journal:  J Am Coll Cardiol       Date:  2011-02-01       Impact factor: 24.094

3.  Polymorphism of CYP11B2 determines salt sensitivity in Japanese.

Authors:  Naoharu Iwai; Kazuaki Kajimoto; Hitonobu Tomoike; Naoyuki Takashima
Journal:  Hypertension       Date:  2007-02-12       Impact factor: 10.190

4.  Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study.

Authors:  Wenquan Niu; Yue Qi; Shuqin Hou; Xiaoyan Zhai; Wenyu Zhou; Changchun Qiu
Journal:  J Hypertens       Date:  2009-07       Impact factor: 4.844

5.  Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.

Authors:  Ulrik Dixen; Lasse Ravn; Christian Soeby-Rasmussen; Anders Wallin Paulsen; Jan Parner; Erik Frandsen; Gorm B Jensen
Journal:  Cardiology       Date:  2006-09-12       Impact factor: 1.869

6.  Control of CYP11B2 gene expression through differential regulation of its promoter by atypical and conventional protein kinase C isoforms.

Authors:  J G LeHoux; G Dupuis; A Lefebvre
Journal:  J Biol Chem       Date:  2000-12-13       Impact factor: 5.157

7.  Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial.

Authors:  Jay N Cohn; Inder S Anand; Roberto Latini; Serge Masson; Yann-Tong Chiang; Robert Glazer
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

8.  [The prevalence and distributing feature of atrial fibrillation in Xinjiang Uygur Autonomous Region Kazaks adult population].

Authors:  Wu-hong Lu; Hu-yati Mu; Zhi-qiang Liu; Yu-chun Yang; Peng-yi He; Hong-yan Yan; Meila Jia; Lizha Gu; Bati Kong; Deke Shagen
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2012-09

9.  Haplotype analysis of CYP11B2.

Authors:  P C White; L Slutsker
Journal:  Endocr Res       Date:  1995 Feb-May       Impact factor: 1.720

10.  The expression levels of plasma micoRNAs in atrial fibrillation patients.

Authors:  Zheng Liu; Cheng Zhou; Yuzhou Liu; Sihua Wang; Ping Ye; Xiaoping Miao; Jiahong Xia
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

View more
  2 in total

1.  Growth differentiation factor-15 (GDF-15), novel biomarker for assessing atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease.

Authors:  Yong-Ming Zhou; Ming-Jiang Li; Yan-Li Zhou; Le-Le Ma; Xin Yi
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Interactions between CYP11B2 Promoter Methylation and Smoking Increase Risk of Essential Hypertension.

Authors:  Tianlun Gu; Shuqi Mao; Rui Fan; Fade Zhong; Fubao Zhu; Lingmei Hao; Lina Zhang; Fengying Yin
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.